Treatment using implantable devices

    公开(公告)号:GB9816012D0

    公开(公告)日:1998-09-23

    申请号:GB9816012

    申请日:1998-07-22

    Abstract: A method of treatment using implantable devices is disclosed. he method comprises (a) implanting into the body of the human or non-human animal (i) a rectenna capable of receiving electromagnetic radiation in the microwave frequency range and of generating and/or storing electrical energy therefrom, and (ii) an electrically operated therapeutic device arranged to electrical energy from said rectenna; and (b) directing electromagnetic radiation in the microwave frequency range from a source external to the body being treated towards the position of the implanted rectenna so as to genera electrical energy to actuate said therapeutic device.

    42.
    发明专利
    未知

    公开(公告)号:DK537087D0

    公开(公告)日:1987-10-14

    申请号:DK537087

    申请日:1987-10-14

    Abstract: The invention is concerned with the use of certain fatty acids and inhibitors of an enzyme in effecting modifications to the lipid structure of cell membranes. The invention also relates to the formulation of pharmaceutical compositions and medicaments and to such products per se; to the treatment of a variety of clinical and veterinary disorders associated with a lowering of the saturation index of cell membranes, including malignancies, viral disorders and AIDS; and to the use of the active materials of the invention in the relief of pain. The active principals in the present invention are saturated fatty acids having from 12 to 28 carbon atoms in the alkyl chain, e.g. stearic acid, or pharmaceutically acceptable derivatives thereof; and inhibitors of the enzyme DELTA -9 desaturase, e.g. sterculic acid and malvalic acid or pharmacologically active derivatives or analogues thereof.

    Pharmaceutical composition
    43.
    发明专利

    公开(公告)号:GB0917359D0

    公开(公告)日:2009-11-18

    申请号:GB0917359

    申请日:2009-10-02

    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.

    Pharmaceutical composition
    44.
    发明专利

    公开(公告)号:GB0818725D0

    公开(公告)日:2008-11-19

    申请号:GB0818725

    申请日:2008-10-13

    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.

    Implantable pump
    48.
    发明专利

    公开(公告)号:GB2350794A

    公开(公告)日:2000-12-13

    申请号:GB9909074

    申请日:1999-04-20

    Inventor: HABIB NAGY ADLY

    Abstract: A pump system for use in the treatment of ascites. A saphenous vein is severed and connected into the peritoneal cavity. Ascitic fluid which has accumulated in the peritoneum cavity is pumped out of the cavity and into the vascular system via the anastomosed saphenous vein. An implantable pump situated in the fluid flow path increases the efficiency of evacuation of the peritoneum. Provision is made for accurately controlling the pump system with the aid of pressure sensors located in the flow path. Cancerous cells within the fluid can be filtered out and thus prevented from circulating into the vascular system, and a reservoir compartment can be provided for needle aspiration thereof. The pump may be monitored and/or powered remotely.

    Implantable pump for ascites treatment

    公开(公告)号:GB9909074D0

    公开(公告)日:1999-06-16

    申请号:GB9909074

    申请日:1999-04-20

    Applicant: HABIB NAGY A

    Abstract: A pump system for use in the treatment of ascites. A saphenous vein is severed and connected into the peritoneal cavity. Ascitic fluid which has accumulated in the peritoneum cavity is pumped out of the cavity and into the vascular system via the anastomosed saphenous vein. An implantable pump situated in the fluid flow path increases the efficiency of evacuation of the peritoneum. Provision is made for accurately controlling the pump system with the aid of pressure sensors located in the flow path. Cancerous cells within the fluid can be filtered out and thus prevented from circulating into the vascular system, and a reservoir compartment can be provided for needle aspiration thereof. The pump may be monitored and/or powered remotely.

Patent Agency Ranking